These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 8101695

  • 1. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M, Harford WV, Fisher RS, Sampliner RE, Murray SB, Greski-Rose PA, Jennings DE.
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [Abstract] [Full Text] [Related]

  • 2. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D.
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group.
    Castell DO, Richter JE, Robinson M, Sontag SJ, Haber MM.
    Am J Gastroenterol; 1996 Sep; 91(9):1749-57. PubMed ID: 8792693
    [Abstract] [Full Text] [Related]

  • 4. Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group.
    Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Haber M.
    Am J Gastroenterol; 1996 Sep; 91(9):1758-65. PubMed ID: 8792694
    [Abstract] [Full Text] [Related]

  • 5. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T, Lemaire M, Agostini H.
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
    [Abstract] [Full Text] [Related]

  • 6. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
    Lanza F, Goff J, Scowcroft C, Jennings D, Greski-Rose P.
    Am J Gastroenterol; 1994 Aug; 89(8):1191-200. PubMed ID: 8053433
    [Abstract] [Full Text] [Related]

  • 7. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D, Paré P, Pericak D, Pyzyk M, Canadian Pantoprazole GERD Study Group.
    Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
    [Abstract] [Full Text] [Related]

  • 8. Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients.
    Richter JE, Kahrilas PJ, Sontag SJ, Kovacs TO, Huang B, Pencyla JL.
    Am J Gastroenterol; 2001 Nov; 96(11):3089-98. PubMed ID: 11721754
    [Abstract] [Full Text] [Related]

  • 9. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.
    Howden CW, Henning JM, Huang B, Lukasik N, Freston JW.
    Am J Gastroenterol; 2001 Jun; 96(6):1704-10. PubMed ID: 11419818
    [Abstract] [Full Text] [Related]

  • 10. A placebo-controlled dose-ranging study of lansoprazole in the management of reflux esophagitis.
    Earnest DL, Dorsch E, Jones J, Jennings DE, Greski-Rose PA.
    Am J Gastroenterol; 1998 Feb; 93(2):238-43. PubMed ID: 9468251
    [Abstract] [Full Text] [Related]

  • 11. [Cost-effectiveness of the treatment of reflux esophagitis: proton pump inhibitor versus histamine-2-receptor antagonist].
    Habu Y, Oyasu K, Wakamatsu T, Sumitomo Y, Kiyota K, Inokuchi H, Kawai K.
    Nihon Rinsho; 2000 Sep; 58(9):1881-5. PubMed ID: 11004820
    [Abstract] [Full Text] [Related]

  • 12. Clinical review of lansoprazole.
    Lockhart SP.
    Br J Clin Pract Suppl; 1994 Sep; 75():48-55; discussion 56-7. PubMed ID: 8060802
    [Abstract] [Full Text] [Related]

  • 13. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE, Sabesin SM, Kogut DG, Kerr RM, Wruble LD, Collen MJ.
    Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
    [Abstract] [Full Text] [Related]

  • 14. [Long-term maintenance treatment of reflux esophagitis resistant to H2-RA with PPI (lansoprazole)].
    Endo M, Sugihara K.
    Nihon Rinsho; 2000 Sep; 58(9):1865-70. PubMed ID: 11004817
    [Abstract] [Full Text] [Related]

  • 15. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA, Kuppermann M, Richter JE.
    Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
    [Abstract] [Full Text] [Related]

  • 16. Lansoprazole: a comprehensive review.
    Zimmermann AE, Katona BG.
    Pharmacotherapy; 1997 Dec; 17(2):308-26. PubMed ID: 9085323
    [Abstract] [Full Text] [Related]

  • 17. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
    Campbell DR, Haber MM, Sheldon E, Collis C, Lukasik N, Huang B, Goldstein JL.
    Am J Gastroenterol; 2002 Sep; 97(9):2208-14. PubMed ID: 12358234
    [Abstract] [Full Text] [Related]

  • 18. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A, Stimac D, Vceva A, Rubinić M, Ivandić A, Ivanis N, Horvat D, Volarić M, Karner I.
    Acta Med Croatica; 1997 Sep; 51(3):171-4. PubMed ID: 9248117
    [Abstract] [Full Text] [Related]

  • 19. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP, Schenk E, Tan G, Snel P, Nelis F.
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [Abstract] [Full Text] [Related]

  • 20. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE, Campbell DR, Kahrilas PJ, Huang B, Fludas C.
    Arch Intern Med; 2000 Jun 26; 160(12):1803-9. PubMed ID: 10871974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.